Top Pharmaceuticals companies in Norway by EBITDA

This ranking features the top 11 Pharmaceuticals companies in Norway ranked by EBITDA, totalling a EBITDA of USD -81.67 M, for January 15, 2025.
#
Name
EBITDA
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 6.26 M
Dec. 31, 2023 USD 4.95 -0.09%

Norway

2
USD 3.64 M
Dec. 31, 2023 USD 2.17 -0.37%

Norway

3
USD 3.11 M
Dec. 31, 2023 USD 1.20 -0.29%

Norway

4
USD -295.21 K
Dec. 31, 2023 USD 3.46 4.14%

Norway

5
USD -670.44 K
Dec. 31, 2023 USD 0.22 4.62%

Norway

6
USD -2.18 M
Dec. 31, 2023 USD 0.11 -3.45%

Norway

7
USD -3.15 M
Dec. 31, 2023 USD 1.36 33.77%

Norway

8
USD -6.93 M
Dec. 31, 2023 USD 0.17 -2.50%

Norway

9
USD -18.61 M
Dec. 31, 2023 USD 0.77 -0.80%

Norway

10
USD -21.09 M
Dec. 31, 2023 USD 0.19 2.37%

Norway

11
USD -41.74 M
Dec. 31, 2023 USD 0.23 0.44%

Norway

Frequently Asked Questions
  • Which Pharmaceuticals company in Norway has the highest EBITDA ?

    The Pharmaceuticals company in Norway with the highest EBITDA is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD 6.26 M.

  • Which Pharmaceuticals company in Norway has the lowest EBITDA ?

    The Pharmaceuticals company in Norway with the lowest EBITDA is Nykode Therapeutics AS (Oslo Stock Exchange: NYKD.OL) at USD -41.74 M.